New dental implant system under study for tooth loss
NCT ID NCT05498662
First seen Jun 26, 2026 · Last updated Jul 29, 2026 · Updated 3 times
Summary
This study is testing the T3 Pro dental implant system in 60 adults who need one or more missing teeth replaced. Participants receive the implant and a permanent crown within 4 months, then are followed for 2 years to check how well the implant stays in place and whether bone loss occurs. The goal is to see if this implant is safe and effective for everyday use.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- T3 Pro dental implant system
- What this could lead to
- If successful, this could confirm that the T3 Pro implant is a safe and effective option for replacing missing teeth.
- What could go wrong
- This is a small, observational study with only 60 participants and no comparison group, so results may not apply to everyone. Implants can fail or cause bone loss over time.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 60 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Sep 2022
- Expected to finish
-
Apr 2028
An estimate. End dates often move.
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Qualified patients (each patient having at least 1 tooth site treated) newly diagnosed with needing a dental implant (or more than one) in one or more tooth sites (edentulous or sick tooth in need of extraction) in the maxilla and/or mandible. Patients who have had prior implants in the treatment site that have failed (in need of revision) are not eligible for inclusion. \*Potential study participants please note: there are costs associated with the treatment(s) provided in this study.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Patients at least 18 years of age 2. Patients for whom a decision has already been made to use a dental implant in an edentulous or immediately removed tooth site to be fully restored in the mandible or maxilla. 3. Site planned for immediate extraction and immediate restoration should have intact bony walls- Type I (as described in Special Procedures section) sockets as verified by CBCT and during surgery; Type II may be considered at the discretion of the treating clinician 4. Previously extracted sites (healed at least 3-4 months) 5. For all sites, presence of opposing dentition (antagonist may be natural teeth or implant supported prosthesis) that will allow for functional occlusion is essential. 6. The site intended for implant placement should have at least 10mm of alveolar bone height and sufficient restorative space for a restoration; without the need for augmentation except for minor dehiscence, which can be augmented with autogenous bone chips and/or allograft (i.e.: Puros) to improve soft tissue attachment. 7. Patients must be physically able to tolerate conventional surgical and restorative procedures (IV sedation protocols may be used at the discretion of the treating clinician). 8. Patients who provide a signed informed consent. 9. Patients who agree to be evaluated for each study visit. Exclusion Criteria: 1. Patients with known systemic diseases such as diabetes, endocrine disease, heart disease, immuno-compromised, or mental disorders that are uncontrolled at the time of enrollment. 2. Patients with current use of bisphosphonates. 3. Patients with active infection or severe inflammation in the areas intended for treatment. 4. Patients with more than10 cigarette per day smoking habit. 5. Patients with a history of therapeutic radiation to the head or jaw. 6. Patients who are known to be pregnant at the screening visit or planning to become pregnant within 6 months of study enrollment. 7. Patients with evidence of untreated severe parafunctional habits such as bruxing or clenching. 8. Patients who have previously failed dental implants at the site intended for study implant placement 9. Patients with HIV or active Hepatitis infection. 10. Patients with a history of untreated generalized severe periodontitis.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Tooth loss are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Louisiana State University Health Sciences Center
New Orleans, Louisiana, 70119, United States
-
University of Minnesota
Minneapolis, Minnesota, 55455, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Drilling through roots: a new path to steadier dental implants?
- The race to save jawbone: four socket techniques go head to head
- Can a custom healing cap preserve gum and bone after tooth extraction?
- Can a single drill match full computer guidance for dental implants?
- Tooth-Enamel gel may boost dental implant healing
- A custom-shaped healing cap may keep gums and bone in better shape after tooth extraction and implant placement